Dietmar Berger M.D., Ph.D.
Board Member
Arcus Biosciences, Inc. (RCUS)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Dietmar Berger M.D., Ph.D.
Dietmar Berger M.D., Ph.D. is recorded as Board Member at Arcus Biosciences, Inc. (RCUS). Arcus Biosciences, Inc. reported in an 8-K filed February 6, 2025 that Dietmar Berger M.D., Ph.D. was appointed Class II director, effective February 6, 2025.
“On February 6, 2025, the Board appointed Dietmar Berger M.D., Ph.D., as a Class II director to fill the vacancy left by Dr. Parsey's resignation.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2025-02-06–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Arcus Biosciences, Inc.
Other people whose current roles at this company are on record from its filings.
- Terry Rosen CEO, Board Member
- Robert C. Goeltz II CFO, Chief Accounting Officer
- Robert Goeltz CFO
- Jennifer Jarrett COO
- Carolyn Tang General Counsel
- Alexander Azoy Chief Accounting Officer
- Andrew Perlman Board Member
- Andrew Perlman, MD, Ph.D. Board Member
- Antoni Ribas Board Member
- David L. Lacey, M.D. Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.